Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin for prevention of catheter-related bladder discomfort after transurethral resection of bladder tumor
KCT0000498Phase 4Recruiting
- Sponsor
- Astellas Pharma
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in bladder cancer, cystitis, sponsored by Astellas Pharma. Started Apr 2012; status: recruiting.
02
Drugs
solifenacin
03
Conditions
bladder cancercystitis
Beyond the preview
Go deeper on KCT0000498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000498.